Dexmethylphenidate Hcl is the dextrorotatory enantiomer of methylphenidate, prescribed for attention deficit hyperactivity disorder (ADHD). Aloglutamol can cause an increase in the absorption of ...

Avoid alcohol intake while using Dexmethylphenidate as it can cause side effects like drowsiness, dizziness and impaired concentration (1 Trusted Source National Institute on Alcohol and Alcoholism.

CTx-1301 is designed to deliver 3 separate releases of medication at different times and in different ratios. Topline data were announced from a phase 3 trial evaluating CTx-1301 for the treatment of ...

KANSAS CITY, Kan., June 08, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...

KANSAS CITY, Kan., May 03, 2023 (GLOBE NEWSWIRE) -- Cingulate (CING) Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...

A Prescription Drug User Fee Act target date of May 31, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...

Corium, Inc. announced that its poster, “Serdexmethylphenidate/d-Methylphenidate Capsules for Children With ADHD: Effects on SKAMP-C Evaluated Over 13 Hours in a ...

KANSAS CITY, Kan., July 11, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...

The ‘Dexmethylphenidate Market study‘ 2020 offers an in-depth analysis pertaining to potential drivers fueling this industry. The study also elucidates valuable insights about profitability position, ...